Dalton Pharma Services Growth, Revenue, Number of Employees and Funding

Overview

Location:
Toronto, ON Canada
Total Funding:N/A
Industry:Pharma
Founded:1986
Lead Investor(s):N/A
Press

Estimated Revenue & Financials

  • Dalton Pharma Services's estimated revenue is currently $23.1M per year.
  • Dalton Pharma Services's estimated revenue per employee is $184920

Employee Data

  • Dalton Pharma Services has 125 Employees.
  • Dalton Pharma Services grew their employee count by 4% last year.
  • Dalton Pharma Services currently has 1 job openings.

What Is Dalton Pharma Services?

Dalton is a contract pharmaceutical manufacturer which provides completely integrated chemistry, development, and manufacturing to biotechnology and pharmaceutical clients around the world. In its 42,000 sq. ft. facility, Dalton operates cGMP manufacturing of Active Pharmaceutical Ingredients (APIs), sterile injectables, finished drug products in vials or syringes, as well as solid oral dosage forms. APIs can be produced in gram to kilogram quantities, including sterile APIs. Dalton contract capabilities can support you at any stage of the regulatory process (Phase I, II, III, or commercial). Development services include chemistry and process development, medicinal chemistry, custom drug conjugation, targeted drug delivery systems, analytical method development and validation, ICH stability testing, formulation, and polymorphism screening. Dalton also supports the industry's pharmaceutical research programs with a catalog of 2,500 reference standards, building blocks, metabolites, and impurities with its Dalton Research Molecules business.

keywords:N/A

125

Number of Employees

$23.1M

Revenue (est)

1

Current Jobs

4%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Turnkey Modular...
$5.8M3530%
HLS Therapeutic...
$7M4114%
PharmEng Techno...
$27.1M15713%
Allphase Clinic...
$7M3712%
Janssen
$1342.5M71657%
Fresenius Kabi ...
$19.8M10821%
Everest Clinica...
$26.9M16418%
Robarts Clinica...
$41.4M24014%
Novapharm Limit...
N/A932%
Dalton Pharma S...
$23.1M1254%